X4 Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $6.01 –$6.92 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen five negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

X4 Pharmaceuticals currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%. 

X4 Pharmaceuticals, Inc. Price

X4 Pharmaceuticals, Inc. price | X4 Pharmaceuticals, Inc. Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Repligen Corporation (RGEN Quick QuoteRGEN - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>